Bromelain down-regulates myofibroblast differentiation in an in vitro wound healing assay

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 386, Issue 10, 2013, Pages 853-863

  Aichele, Kathrin ^a   Bubel, Monika ^a   Deubel, Gunther ^b   Pohlemann, Tim ^a   Oberringer, Martin ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Zentrum Am Boxberg (ZAB)   (Germany)

Author keywords

Bromelain; Co culture; Endothelial cell; Fibroblast; Hypoxia; Interleukin 6 (IL 6); Myofibroblast; Wound

Indexed keywords

BROMELAIN; INTERLEUKIN 6;

APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FIBROBLAST; HUMAN; HUMAN CELL; HYPOXIA; MICROVASCULAR ENDOTHELIAL CELL; MONOCULTURE; MYOFIBROBLAST; WOUND HEALING;

BROMELAINS; CELL CYCLE; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DOWN-REGULATION; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; INTERLEUKIN-6; WOUND HEALING;

EID: 84884670723     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-013-0890-z     Document Type: Article

References (60)

1. Bahde R, Palmes D, Minin E, Stratmann U, Diller R, Haier J, Spiegel H-U (2007) Bromelain ameliorates hepatic microcirculation after warm ischemia. J Surg Res 139:88-96
2. Borthwick LA, Wynn TA, Fisher AJ (2013) Cytokine mediated tissue fibrosis. Biochim Biophys Acta 1832(7):1049-1060
3. Breit S, Bubel M, Pohlemann T, Oberringer M (2011) Erythropoietin ameliorates the reduced migration of human fibroblasts during in vitro hypoxia. J Physiol Biochem 67:1-13
4. Brown SA, Coimbra M, Coberly D, Chao J, Rohrich RJ (2004) Oral nutritional supplementation accelerates skin wound healing: a randomized, placebo-controlled, double-arm, crossover study. Plast Reconstr Surg 114(1):237-244
5. Chobotovaa K, Vernallisc AB, Majidb FA (2010) Bromelain's activity and potential as an anti-cancer agent: current evidence and perspectives. Cancer Lett 290(2):148-156
6. Desser L, Holomanova D, Zavadova E, Pavelka K, Mohr T, Herbacek I (2001) Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood. Cancer Chemother Pharmacol 47(Suppl):S10-S15
7. Diegelmann RF, Evans MC (2004) Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9:283-289
8. Dill-Müller D, Tilgen W (2005) Bewährte und aktuelle Verfahren in der Wundheilung. Hautarzt 56:411-422
9. Duffield JS, Lupher M, Thannickal VJ, Wynn TA (2013) Host responses in tissue repair and fibrosis. Annu Rev Pathol Mech Dis 8:241-276
10. Eneroth M, Persson BM (1993) Risk factors for failed healing in amputation for vascular disease. A prospective, consecutive study of 177 cases. Acta Orthop Scand 64:369-372
11. Enoch S, Price PE (2004a) Should alternative endpoints be considered to evaluate outcomes in chronic recalcitrant wounds? World Wide Wounds October 2004; Available from http://www.worldwidewounds.com/2004/october/Enoch-Part2/ Alternative-Enpoints-To-Healing.html. Accessed 6 May 2013
12. Enoch S, Price PE (2004b) Cellular, molecular and biochemical differences in the pathophysiology of healing between acute wounds, chronic wounds, and wounds in the aged. World Wide Wounds August 2004; Available from http://www.worldwidewounds.com//2004/august/Enoch/Pathophysiology-Of-Healing. html. Accessed 6 May 2013
13. Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E (2003) HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534:65-75
14. Fitzhugh DJ, Shan S, Dewhirst MW, Hale LP (2008) Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin Immunol 128(1):66-74
15. Franz RW, Parks A, Shah KJ, Hankins T, Hartman JF, Wright ML (2009) Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease. J Vasc Surg 50:1378-1390
16. Gallucci RM, Lee EG, Tomasek JJ (2006) IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice. J Invest Dermatol 126:561-568
17. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133(4):1710-1715
18. Gharaee-Kermani M, Phan SH (2001) Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des 7:1083-1103
19. Gotlieb AI, Heggeness MH, Ash JF, Singer SJ (1979) Mechanochemical proteins, cell motility and cell-cell contacts: the localization of mechanochemical proteins inside cultured cells at the edge of an in vitro "wound". J Cell Physiol 100(3):563-578
20. Hopf HW, Rollins MD (2007) Wounds: an overview of the role of oxygen. Antioxid Redox Signal 9(8):1183-1192
21. Hu W, Wang AM, Wu SY, Zhang B, Liu S, Gou YB, Wang JM (2011) Debriding effect of bromelain on firearm wounds in pigs. J Trauma 71:966-972
22. Hunt TK (1988) The physiology of wound healing. Ann Emerg Med 17:1265-1273
23. Iida T, Mine S, Fujimoto H, Suzuki K, Minami Y, Tanaka Y (2002) Hypoxia-inducible factor-1 alpha induces cell cycle arrest of endothelial cells. Genes Cells 7:143-149
24. Kannon GA, Garrett AB (1995) Moist wound healing with occlusive dressings. A clinical review. Dermatol Surg 21:583-590
25. Kisseleva T, Brenner DA (2008) Mechanisms of fibrogenesis. Exp Biol Med 233:109-122
26. Königs I, Jester I Erste Ergebnisse einer prospektiven Studie mit Debrase Gel Dressing zum enzymatischen Wunddebridment bei kindlichen Verbrennungen. 26. Jahrestagung der deutschsprachigen Arbeitsgemeinschaft für Verbrennungsbehandlung (DAV 2008); Available from http://www.egms.de/ de/meetings/dav2008/08dav21.shtml. Accessed 11 Mar 2013
27. Krieger Y, Bogdanov-Berezovsky A, Gurfinkel R, Silberstein E, Sagi A, Rosenberg L (2012) Efficacy of enzymatic debridement of deeply burned hands. Burns 38:108-112
28. Lebrun E, Tomic-Canic M, Kirsner RS (2010) The role of surgical debridement in healing of diabetic foot ulcers. Wound Repair Regen 18:433-438
29. Liechty KW, Adzick NS, Crombleholme TM (2000) Diminished Interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine 12(6):671-676
30. Luckett-Chastain LR, Gallucci RM (2009) Interleukin (IL)-6 modulates transforming growth factor-β expression in skin and dermal fibroblasts from IL-6-deficient mice. Br J Dermatol 161:237-248
31. MacKay D, Miller AL (2003) Nutritional support for wound healing. Altern Med Rev 8(4):359-377
32. Mateo RB, Reichner JS, Albina JE (1994) Interleukin-6 activity in wounds. Am J Physiol 266:R1840-R1844
33. Maurer HR (2001) Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci 58:1234-1245
34. Moodley YP, Scaffidi AK, Misso NL, Keerthisingam C, McAnulty RJ, Laurent GJ, Mutsaers SE, Thompson PJ, Knight DA (2003) Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. Am J Pathol 163(1):345-354
35. O'Reilly S, Ciechomska M, Cant R, Hügle T, van Laar JM (2012) Interleukin-6, its role in fibrosing conditions. Cytokine Growth Factor Rev 23:99-107
36. Oberringer M, Meins C, Bubel M, Pohlemann T (2007) A new in vitro wound model based on the co-culture of human dermal microvascular endothelial cells and human dermal fibroblasts. Biol Cell 99(4):197-207
37. Onken JE, Greer PK, Calingaert B, Hale LP (2008) Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro. Clin Immunol 126(3):345-352
38. Paczek L, Gaciong Z, Bartlomiejczyk I, Sebekova K, Birkenmeier G, Heidland A (2001) Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats. Drugs Exp Clin Res 27(4):141-149
39. Pappas PJ, Lal BK, Cerveira JJ, Padberg FT, Duran WN (2005) Causes of severe chronic venous insufficiency. Semin Vasc Surg 18(1):30-35
40. Paquet P, Piérard GE (1996) Interleukin-6 and the skin. Int Arch Allergy Immunol 109(4):308-317
41. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB (1999) Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277:C1-C19
42. Purins K, Enblad P, Sandhagen B, Lewén A (2010) Brain tissue oxygen monitoring: a study of in vitro accuracy and stability of neurovent-PTO and licox sensors. Acta Neurochir 152(4):681-688
43. Rose B, Herder C, Löffler H, Meierhoff G, Schloot NC, Walzand M, Martin S (2005) Dose-dependent induction of IL-6 by plant-derived proteases in vitro. Clin Exp Immunol 143:85-92
44. Rosenberg L, Krieger Y, Silberstein E, Arnon O, Sinelnikov IA, Bogdanov-Berezovsky A, Singer AJ (2012) Selectivity of a bromelain based enzymatic debridement agent: a porcine study. Burns 38:1035-1040
45. Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M, Babilas P (2010) Oxygen in acute and chronic wound healing. Br J Dermatol 163(2):257-268
46. Schwarz F, Jennewein M, Bubel M, Holstein JH, Pohlemann T, Oberringer M (2013) Soft tissue fibroblasts from well healing and chronic human wounds show different rates of myofibroblasts in vitro. Mol Biol Rep 40:1721-1733
47. Silverstein P (1992) Smoking and wound healing. Am J Med 93:22S-24S
48. Singer AJ, Taira BR, Anderson R, McClain SA, Rosenberg L (2011) Reepithelialization of mid-dermal porcine burns after rapid enzymatic debridement with Debrase®. J Burn Care Res 32:647-653
49. Smith PD (2001) Update on chronic-venous-insufficiency-induced inflammatory processes. Angiology 52:S35-S42
50. Smith PC (2006) The causes of skin damage and leg ulceration in chronic venous disease. Int J Low Extrem Wounds 5(3):160-168
51. Statistisches Bundesamt, 12. koordinierte Bevö lkerungsvorausberechnung; Available from http://www.destatis.de/ bevoelkerungspyramide. Accessed 11 Mar 2013
52. Tandara AA, Mustoe TA (2004) Oxygen in wound healing-more than a nutrient. World J Surg 28(3):294-300
53. Todaro G, Matsuya Y, Bloom S, Robbins A, Green H (1967) In: Defendi V, Stoker M (eds) Wistar Institute Symposium 7. Wistar Institute Press, Philadelphia, pp 87-98
54. Trabold O, Wagner S, Wicke C, Scheuenstuhl H, Hussain Z, Rosen N, Seremetiev A, Becker HD, Hunt TK (2003) Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing. Wound Repair Regen 11:504-509
55. Tucci M, Hammerman SI, Furfaro S, Saukonnen JJ, Conca TJ, Farber HW (1997) Distinct effect of hypoxia on endothelial cell proliferation and cycling. Am J Physiol 272:C1700-C1708
56. Vyas B, Ishikawa K, Duflo S, Chen X, Thibeault SL (2010) Inhibitory effects of HGF and IL-6 on TGF-β1 mediated vocal fibroblast-myofibroblast differentiation. Ann Otol Rhinol Laryngol 119(5):350-357
57. Wu SY, Hu W, Zhang B, Liu S, Wang JM, Wang AM (2012) Bromelain ameliorates the wound microenvironment and improves the healing of firearm wounds. J Surg Res 176:503-509
58. Wynn TA (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117:524-529
59. Yarnold J, Brotons MC (2010) Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol 97(1):149-161
60. Zetter BR, Chen LB, Buchanan JM (1976) Effects of protease treatment on growth, morphology, adhesion, and cell surface proteins of secondary chick embryo fibroblasts. Cell 7:407-412